期刊文献+

心脏干细胞移植治疗缺血性心脏病的研究进展 被引量:5

下载PDF
导出
摘要 缺血性心脏病患者往往死于心力衰竭(心衰),而目前对于难治性心衰最好的治疗方法是心脏移植。但随着干细胞和祖细胞在再生潜能治疗和预防心衰方面的深入研究,心脏干细胞移植有望成为治疗缺血性心脏病最理想的方法。本文旨在对心脏干细胞移植治疗缺血性心脏病的研究现状及所面临的问题进行综述。
作者 李玲 石蓓
出处 《中国循环杂志》 CSCD 北大核心 2015年第3期290-292,共3页 Chinese Circulation Journal
基金 国家自然科学基金(81360021)
  • 相关文献

参考文献28

  • 1Martinez EC, Kofidis T. Adult stem cells for cardiac tissue engineering. J Mol Cell Cardiol, 2011, 50: 312-319.
  • 2Heldman AW, Zambrano JP, Hare JM. Cell therapy for heart disease: where are we in 2011. J Am Coll Cardiol, 2011, 57: 466-468.
  • 3Chamuleau SA, Vrijsen KR, Rokosh DG, et al. Cell therapy for ischaemic heart disease: focus on the role of resident cardiac stem cells. Neth Heart J, 2009, 17: 199-207.
  • 4Mohsin S, Siddiqi S, Collins B, Sussman MA. Empowering adult stem cells for myocardial regeneration. Circ Res, 2011,109 : 1415-1428.
  • 5尤宏钊,张健.干细胞治疗心肌梗死和缺血性心力衰竭的临床应用进展[J].中国循环杂志,2014,29(6):476-478. 被引量:7
  • 6刘盛,胡盛寿,宋云虎,王巍,郑哲,杨克明,张浩,段福建,陆敏杰,沈锐,魏英杰,张晓玲.冠状动脉旁路移植术同期自体骨髓干细胞移植治疗晚期缺血性心脏病临床研究的早期结果[J].中国循环杂志,2009,24(4):300-303. 被引量:4
  • 7Oskouei BN, Lamirault G, Joseph C, et al. Hare JM. Increased potency of cardiac stem cells compared with bone marrow mesenchymal stem cells in cardiac repair. Stem Cells Transl Med, 2012, 1: 116-124.
  • 8Hierlihy AM, Scale P, Lobe CG, et al. The postnatal heart contains a myocardial stem cell p-opulation. FEBS Lett, 2002, 530 : 239-243.
  • 9Quaini F, Urbanek K, Behrami AP, et al. Chimerism of the transplanted heart. N Engl J Med, 2002, 346: 5-15.
  • 10Eberhard D, Jockusch H. Patterns of myocardialh is togenesis as revealed by mouse chimer-as. Dev Biol, 2005, 278: 336- 346.

二级参考文献29

  • 1任晓庆,浦介麟,张澍,贾玉和,赵欣然,孟亮,王方正.自体骨髓间叶干细胞诱导分化移植重建窦房结起搏功能的实验研究[J].中国循环杂志,2004,19(6):462-465. 被引量:15
  • 2杨国胜,杨跃进,白东峰,杨伟宪,高润霖,陈在嘉.经冠状动脉移植骨髓间质干细胞治疗心肌梗死的实验研究[J].中国循环杂志,2007,22(1):20-23. 被引量:8
  • 3Strauer RE, Brehm M, Zeus T, et al. Repair of infracted myocardium by autologous intraeoronary mononuelear bone marrow cell transplantation in humans. Circulation ,2002,106 : 1913-1918.
  • 4Jozef B, Stephanie D, Helmut D. The consensus of the task force of the european society of cardiology concerning the clinical investigation of the use of autologous adult stem cells for repair of the heart. Eur Heart J, 2006,27 ( 11 ) : 1338 -1340.
  • 5Eagle KA, Guyton RA, Davidoff R, et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery : a report of the american College of cardiology/american heart association task force on practice guidelines. Circulation ,2004,110 ( 14 ) : e340-437.
  • 6Vulliet PR, Greeley M, Halloran SM, et al. Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. The Lancet ,2004,363:783-784.
  • 7Paolo B, Mara R, Stan G, et al. Bone marrow stromal stem cells: Natrue, biology, and potential applications. Stem Cells, 2001,19 : 180- 19:2.
  • 8Cimochowski GE, Harostock MD, Foldes PJ. et al. Minimal operative mortality in patients undergoing coronary artery bypass with significant left ventrieular dysfunction by maximization of metabolic and mechanical support. J Thorac Cardiovasc Surg, 1997,113 (4) :655-664.
  • 9Lipinski MJ, Biondi-Zoccai GG, Abbate A, et al. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction:a collaborative systematic review and meta-analysis of controlled clinical trials. J Am Coil Cardiol, 2007,50 ( 18 ) : 1761- 1767.
  • 10Blin G, Nury D, Stefanovic S, et al. A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates. J Clin Invest, 2010, 120: 1125-1139.

共引文献9

同被引文献68

  • 1王新,郭静华.甲状腺素对老年亚临床甲状腺功能减退患者血脂、血糖、血尿酸水平的影响[J].中国老年学杂志,2014,34(3):637-639. 被引量:23
  • 2van der Bogt KE, Sheikh AY, Sehrepfer S. et al. Comparison of different adult stem cell types for treatment of myocardial isvhemia. Circulation, 2008, 118: S121-S129.
  • 3Janssens S, Dubois C, Bogaert J, et al. Autologous bone marrow- derived stem-cell transfer in patienls with ST-segment elevati,m myocardial infarction: double-blind, randomized controlled trial. Lancet, 2006, 367:113-121.
  • 4Hare JM, Traverse JH, Henry TD, el al. A randomized, double-Dlind, placebo-controlled, dose-escalation study of intravenous aduh human mesenehymal stem cells( prochymal )after acute myocardial infaretion. J Am Coll Cardiol, 2009, 54: 2277-2286.
  • 5Ellison GM, Vicinanza C, Smith A J, et al. Aduh c-kitpos cardiac stem c;-lls are necessary and sufficient for funeti.nal cardiac regeneration and Repair. Cell, 2013, 8: 827-842.
  • 6Chugh AR, Beache GM, Loughran JH, el al. Administratitm of cardiac stem cells in patients with ischemic cardiomyopalhy: the SC1PIO trial: surgical aspects and interim analysis of myocardial function and viability by magnelic resonance. Circulation, 2012, 126: S54-S64.
  • 7Bolli R, Chugh AR, D' Amario D, et al. Cardiac stem cells in patients wilhischaemic cardiomyopalhy (SCIPIO): initial restllls of a randomized phaselrial. Lancet, 2011,378: 1847-1857.
  • 8van Berlo JH, Kanisicak O, Maillet M, el al. c-kil+cells minimally contFih cardiomyocytes to the heart. Nature, 2014, 509: 337-345.
  • 9Lee RC, Feimbaum RL, Ambros V, et al. The Gelegans heterochronic gene lin-4 encodes snmll RNAs with anlisense complementarily to lin-14. Cell, 1993, 75: 843-854.
  • 10Hunlzinger E,Izaurralde E. Gene silencing by miero RNAs: contrihulicms of Iranstational repression and rnRNA decay. Nat Rev Genet, 2011, 12:99-110.

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部